Literature DB >> 10886682

Influence of different fixation procedures on the quantification of infarction and oedema in a rat model of stroke.

K Overgaard1, P Meden.   

Abstract

In pharmacodynamic studies using focal ischaemia models, the size of the infarct measured by quantitative histology is the most important outcome measure. Precise, unbiased and reproducible assessment of infarct volume is of foremost importance. A frequent problem in interventional stroke models is the evaluation of infarcts in animals found dead, where instant post-mortem fixation of the brain cannot be performed. The purpose of this study was to investigate possible bias from perfusion, immediate and 3-h post-mortem delayed immersion fixation on the measured volumes of cerebral infarction, oedema and hemispheres in a rat embolic stroke model. Thirty-six male Sprague-Dawley rats were thromboembolized into the internal carotid artery. After survival for 24 h, the animals were divided into three groups: group 1 - immediate perfusion fixation; group 2 - immediate immersion fixation of the brain; and group 3 - animals left dead for 3 h at room temperature before removal of the brain for immersion fixation. Following histological preparation and evaluation, the volumes of the hemispheres and infarction were measured by quantitative histology and planimetry. Brains fixed by immersion were 7% larger than the perfusion-fixed brains. Delaying the immersion fixation for 3 h may increase hemisphere volume by a further 12%. Independent of the fixation procedure, the size of infarction was approximately 40% of the ipsilateral hemisphere, and the oedema was approximately 11% of the size of the infarct. The used planimetric technique was accurate with measured values within +/- 2% of the factual value. In conclusion, sizes of hemispheres, infarction and oedema in absolute volume measures are influenced by the effect of unwanted variation of brain size caused by biological factors and artificial shrinkage caused by fixation, dehydration and heat treatment of the specimens. Infarction and oedema expressed relatively in per cent of hemisphere and infarct, respectively, are robust measures independent of the investigated fixation procedures.

Entities:  

Mesh:

Year:  2000        PMID: 10886682     DOI: 10.1046/j.1365-2990.2000.00241.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  6 in total

Review 1.  Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives.

Authors:  Marietta Zille; Tracy D Farr; Ingo Przesdzing; Jochen Müller; Clemens Sommer; Ulrich Dirnagl; Andreas Wunder
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

2.  RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).

Authors:  Shimin Liu; Gehua Zhen; Bruno P Meloni; Kym Campbell; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2009-01-01

3.  Continuous Glibenclamide Prevents Hemorrhagic Transformation in a Rodent Model of Severe Ischemia-Reperfusion.

Authors:  Takahiro Igarashi; Cristina Sastre; Zoe Wolcott; W Taylor Kimberly
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-01-12       Impact factor: 2.136

4.  The site of embolization related to infarct size, oedema and clinical outcome in a rat stroke model - further translational stroke research.

Authors:  Karsten Overgaard; Rune S Rasmussen; Flemming F Johansen
Journal:  Exp Transl Stroke Med       Date:  2010-09-17

5.  Glibenclamide-10-h Treatment Window in a Clinically Relevant Model of Stroke.

Authors:  J Marc Simard; Seung Kyoon Woo; Natalia Tsymbalyuk; Oksana Voloshyn; Vladimir Yurovsky; Svetlana Ivanova; Ryan Lee; Volodymyr Gerzanich
Journal:  Transl Stroke Res       Date:  2012-03-07       Impact factor: 6.829

6.  Multi-modal characterization of rapid anterior hippocampal volume increase associated with aerobic exercise.

Authors:  Adam G Thomas; Andrea Dennis; Nancy B Rawlings; Charlotte J Stagg; Lucy Matthews; Martyn Morris; Shannon H Kolind; Sean Foxley; Mark Jenkinson; Thomas E Nichols; Helen Dawes; Peter A Bandettini; Heidi Johansen-Berg
Journal:  Neuroimage       Date:  2015-12-02       Impact factor: 6.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.